Is ADMA overvalued right now?
A stock is overvalued when its market price sits above a reasonable fair value range. Use the live snapshot on this page for ADMA, then validate with fundamentals and peer multiples.
ADMA Biologics, Inc. (ADMA) is currently Undervalued by 24.55%
Instant valuation answer
ADMA Biologics, Inc. (ADMA) appears undervalued by approximately 24.55% based on our live valuation percent and intrinsic value estimate derived from DCF, P/E Multiple, and P/S Multiple models. Valuation can still differ across analyst models, growth expectations, and risk assumptions.
- Upside (live) 24.55% (from live valuation API)
- Confidence (live) 6.5/10 (Moderate)
Confidence Score is based on the magnitude of upside or downside vs intrinsic value.
Fair value estimate
Unlock fair valueCurrent price
$9.21
Stock valuation checker
Search our company database (same as the site header). Choose a result or type a ticker and press Check valuation.
Explore Our Valuation Calculators
Why is ADMA Biologics, Inc. overvalued or undervalued?
For ADMA Biologics, Inc., intrinsic value ties fair value to sustainable cash generation; with the stock below that level, the snapshot reads as a discount versus fundamentals rather than a pure sentiment call.
Historical valuation for ADMA shows cycles where multiples expanded and compressed; today’s positioning rhymes more with defensive pricing than the mid-range of its recent history.
Market expectations boil down to growth, risk, and return on capital—current levels leave more room for upside if execution is steady. Cross-check with live ratios when your API is connected.
Key metrics
- P/E ratio
- 40.6x
- Revenue growth (TTM y/y)
- 3%
- Profit margin
- 27.1%
- Fair value (model)
- Unlock
Frequently asked questions — ADMA
What is ADMA Biologics, Inc.'s intrinsic value?
Our DCF, P/E Multiple, and P/S Multiple models estimate whether ADMA trades above or below fair value. At $9.21, ADMA Biologics, Inc. currently looks undervalued on this snapshot. Tickerplace Pro unlocks the full dollar fair value estimate.
How is ADMA Biologics, Inc.'s intrinsic value calculated?
Tickerplace calculates ADMA's fair value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We compare the resulting intrinsic value estimate to the live market price to flag undervalued or overvalued positioning.
Is ADMA undervalued right now?
Based on our 2026 valuation models, ADMA Biologics, Inc. (ADMA) appears undervalued at $9.21 with about 24.6% upside to fair value. Treat this as a screen—verify fundamentals on the company profile.
Related companies — valuation
Peers for ADMA: open their overvalued / undervalued view.